RANDALL RUPPEL: Open Payments
NPI 1598749384 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 21 payments from 10 companies in 2025. Trend: 2023 $755 · 2024 $600 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $96 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Corium, LLC | 2 | $14 |
Products named: REXULTI, INGREZZA, Auvelity, AUSTEDO XR, ABILIFY ASIMTUFII, SPRAVATO, CAPLYTA, Jornay PM.
Industry payments across VA — which companies pay providers there.
